Compass Therapeutics, Inc.

CMPX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$14-$20-$17-$15
Dep. & Amort.$0-$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$3$3$2
Change in WC$0$5$1$4
Other Non-Cash$0$0$0-$0
Operating Cash Flow$0-$12-$13-$9
Investing Activities
PP&E Inv.$0$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$109-$33-$25-$10
Inv. Sales/Matur.$14$27$36$25
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$95-$6$12$15
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0-$1-$0
Financing Cash Flow$129$0-$1-$0
Forex Effect$0$0$0$0
Net Chg. in Cash$23-$18-$2$6
Supplemental Information
Beg. Cash$0$42$44$37
End Cash$23$23$42$43
Free Cash Flow$0-$12-$13-$9
Compass Therapeutics, Inc. (CMPX) Financial Statements & Key Stats | AlphaPilot